Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

China · Delayed Price · Currency is CNY

44.87

-0.06 (-0.13%)

At close: Nov 13, 2026

Market Cap	7.80B -31.5%
Revenue (ttm)	1.55B +11.0%
Net Income	172.22M -1.3%
EPS	0.99 -11.7%
Shares Out	173.73M
PE Ratio	45.24
Forward PE	n/a
Dividend	0.20 (0.45%)
Ex-Dividend Date	Aug 28, 2026

Volume	1,314,509
Open	45.64
Previous Close	44.93
Day's Range	44.13 - 46.00
52-Week Range	38.90 - 74.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, cesium iodide, potassium iodate, methyl iodide, diiodomethane, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldis... [Read more]

Industry Chemicals

Sector Materials

Founded 2008

Employees 748

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301617

Full Company Profile

Financial Performance

In 2025, SHE:301617's revenue was 1.46 billion, an increase of 10.30% compared to the previous year's 1.33 billion. Earnings were 172.29 million, a decrease of -19.05%.

Financial Statements